| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biorestorative Therapies, Inc. (BRTX) has 2 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. BRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 187.5K | $76.8K | - | |
| VP | 171.4K | $70.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2018 | Catell Robert B | Director | Buy | 5,000 | $2.80 | $14,000.00 | +6.6% | |
| Sep 26, 2016 | Desmarais John M | Director, 10% Owner | Buy | 80,000 | $3.00 | $240,000.00 | +21.3% | |
| May 18, 2016 | Catell Robert B | Director | Buy | 12,500 | $4.00 | $50,000.00 | +33.3% | |
| Mar 18, 2016 | Desmarais John M | Director, 10% Owner | Buy | 250,000 | $4.00 | $1,000,000.00 | +200.0% | |
| Mar 1, 2016 | Catell Robert B | Director | Buy | 37,500 | $4.00 | $150,000.00 | New | |
| Dec 7, 2015 | Ryan Charles S. | Director | Buy | 6,250 | $4.00 | $25,000.00 | +62.5% | |
| May 27, 2015 | Westbury Trust | 10% Owner | Buy | 14,934,578 | $0.00 | - | +362.9% | |
| May 8, 2015 | Ryan Charles S. | Director | Buy | 200,000 | $0.25 | $50,000.00 | New | |
| Feb 20, 2015 | Westbury Trust | 10% Owner | Buy | 1,000,000 | $0.00 | - | +32.1% |